In addition, we also found that mDCs from HCs and untreated MS patients expressed similar levels of IL-27RA in intracellular stores and thus have a similar capacity to respond to IL-27 (Supplemental Figure S3). This evidence concerns the gene IL27RA and myeloid sarcoma.